5-hydroxytryptamine and platelets: uptake and aggregation in hypoxic pulmonary hypertensive rats

被引:12
作者
Awabdy, D [1 ]
Bryan-Lluka, LJ [1 ]
Wanstall, JC [1 ]
机构
[1] Univ Queensland, Dept Physiol & Pharmacol, Sch Biomed Sci, Brisbane, Qld 4072, Australia
基金
英国医学研究理事会;
关键词
platelet; 5-HT; (5-hydroxytryptamine; serotonin); SERT (serotonin transporter); hypoxic pulmonary hypertension; aggregation;
D O I
10.1016/S0014-2999(02)02734-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Pulmonary hypertension is associated with various alterations in 5-hydroxytryptamine (5-HT) physiology. In this study in platelets from hypoxic pulmonary hypertensive rats (10% O-2; 1 week) and normoxic rats (room air), (i) initial rates of specific [H-3]5-HT uptake were measured and (ii) potentiation of collagen- and ADP-induced aggregation by 5-HT was quantified. The platelet count was almost halved in hypoxic rats. In uptake experiments, there was a decrease in 5-HT uptake in platelets from hypoxic compared with normoxic rats, due to a 36% reduction in the maximal initial rate of uptake. The aggregation experiments showed that 5-HT (1-100 muM) increased the magnitude of responses to collagen and the duration of responses to ADP, but there was no difference between hypoxic and normoxic rats. Abnormalities in platelet function may conceivably lead to increases in plasma 5-HT levels in hypoxic pulmonary hypertension, but are unlikely to aggravate pulmonary thromboembolism. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 26 条
[1]  
AWABDY D, 2001, P AUSTRALAS SOC CLIN, V9, P63
[2]   RELATIVE ACTIVITIES ON AND UPTAKE BY HUMAN BLOOD-PLATELETS OF 5-HYDROXYTRYPTAMINE AND SEVERAL ANALOGS [J].
BORN, GVR ;
JUENGJAROEN, K ;
MICHAL, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1972, 44 (01) :117-+
[3]  
BRINK C, 1988, AM REV RESPIR DIS, V137, pA106
[4]   The role of thrombosis in severe pulmonary hypertension [J].
Chaouat, A ;
Weitzenblum, E ;
Higenbottam, T .
EUROPEAN RESPIRATORY JOURNAL, 1996, 9 (02) :356-363
[5]   Functional effects of 4-aminopyridine (4-AP) on pulmonary and systemic vessels from normoxic control and hypoxic pulmonary hypertensive rats [J].
Doggrell, SA ;
Wanstall, JC ;
Gambino, A .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1999, 360 (03) :317-323
[6]   PULMONARY-HYPERTENSION AND FENFLURAMINE [J].
DOUGLAS, JG ;
MUNRO, JF ;
KITCHIN, AH ;
MUIR, AL ;
PROUDFOOT, AT .
BMJ-BRITISH MEDICAL JOURNAL, 1981, 283 (6296) :881-883
[7]   Treatment with 5-HT potentiates development of pulmonary hypertension in chronically hypoxic rats [J].
Eddahibi, S ;
Raffestin, B ;
Pham, I ;
Launay, JM ;
Aegerter, P ;
Sitbon, M ;
Adnot, S .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1997, 272 (03) :H1173-H1181
[8]   Imbalance between platelet vascular endothelial growth factor and platelet-derived growth factor in pulmonary hypertension -: Effect of prostacyclin therapy [J].
Eddahibi, S ;
Humbert, M ;
Sediame, S ;
Chouaid, C ;
Partovian, C ;
Maître, B ;
Teiger, E ;
Rideau, D ;
Simonneau, C ;
Sitbon, O ;
Adnot, S .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (04) :1493-1499
[9]   Attenuated hypoxic pulmonary hypertension in mice lacking the 5-hydroxytryptamine transporter gene [J].
Eddahibi, S ;
Hanoun, N ;
Lanfumey, L ;
Lesch, KP ;
Raffestin, B ;
Hamon, M ;
Adnot, S .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (11) :1555-1562
[10]   Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells - Relationship with the mitogenic action of serotonin [J].
Eddahibi, S ;
Fabre, V ;
Boni, C ;
Martres, MP ;
Raffestin, B ;
Hamon, M ;
Adnot, S .
CIRCULATION RESEARCH, 1999, 84 (03) :329-336